SIGN UP
LOG IN
Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Benzinga·06/20/2025 12:01:03
Listen to the news
U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Friday.
Shares of Smith & Wesson Brands Inc (NASDAQ:SWBI) fell sharply in pre-market trading after the company reported worse-than-expected fourth-quarter EPS and sales.
Smith & Wesson Brands reported fourth-quarter revenue of $140.8 million, missing analyst estimates of $152.41 million, according to Benzinga Pro. The company reported adjusted earnings of 20 cents per share in the fourth quarter, missing estimates of 23 cents per share.
Smith & Wesson Brands shares dipped 12.6% to $9.51 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Regencell Bioscience Holdings Ltd (NASDAQ:RGC) shares fell 16.2% to $52.96 in pre-market trading after dipping over 18% on Wednesday.
- QuantaSing Group Ltd- ADR (NASDAQ:QSG) fell 12.1% to $11.86 in pre-market trading.
- Aptevo Therapeutics Inc (NASDAQ:APVO) fell 11.9% to $4.52 in pre-market trading. Aptevo Therapeutics shares jumped 82% on Wednesday after the company announced clinical data from its ongoing Phase 1b/2 RAINIER trial evaluating mipletamig.
- Capricor Therapeutics Inc (NASDAQ:CAPR) fell 7.4% to $11.04 in pre-market trading. Capricor Therapeutics recently announced Orphan Drug designation for Becker Muscular Dystrophy.
- Mesoblast Ltd (NASDAQ:MESO) fell 6.5% to $10.94 in pre-market trading.
- Diginex Limited (NASDAQ:DGNX) dropped 6.5% to $43.51 in pre-market trading.
- Himalaya Shipping Ltd. (NASDAQ:HSHP) declined 6.3% to $6.22 in pre-market trading.
- AIRO Group Holdings, Inc. (NASDAQ:AIRO) fell 5.3% to $24.88 in pre-market trading.
Now Read This:
Photo via Shutterstock
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.